BOOK
Critical Care Intravenous Infusion Drug Handbook - E-Book
Gary J. Algozzine | Deborah J. Lilly | Robert Algozzine
(2010)
Additional Information
Book Details
Abstract
Compact and easy to use, this handy reference focuses on the information you need to administer intravenous medications in critical care and emergency environments. Essential coverage of 48 of the most common and complex IV drugs, including drip rate calculation charts, drug calculation formulae, and much more help you safely and efficiently administer IV drugs.
- Fully updated coverage includes the newest IV treatments with magnesium, conivaptan, potassium, and nicardipine, helping you provide the most effective care possible.
- Current drug dosing charts for 48 of the most common, and most difficult to administer, intravenous infusion critical care drugs ensure that the information you need is readily available.
- Quick reference drug compatibility charts provide instant access to this crucial information.
- Drip Rates and Dosing information are arranged in tabular manner for each drug referenced in the text, allowing you to quickly prepare drugs in critical situations.
- A Drug Calculation Formulae section includes a list of the formulae most useful in determining IV drug concentration, doses, and infusion rates, helping you to eliminate memorization errors when calculating these important parameters.
- Calculation factors based on patient weight enable you to quickly change a patient’s infusion dose and titrate the drug to reduce the chance of medication errors.
- Nursing Considerations in each drug monograph offer practical information on administration and monitoring.
- Trade and generic drug name indexes help you find information quickly no matter what name is used.
- A handy reference to ACLS guidelines allows you to quickly see how infusion therapy fits into the ACLS protocol.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Critical Care Intravenous Infusion Drug Handbook | i | ||
| Copyright Page | ii | ||
| Dedication | iii | ||
| Reviewers | iv | ||
| Preface | v | ||
| Contents | vii | ||
| Sources | ix | ||
| Abbreviations | xi | ||
| Drug Calculation Formulae | xvi | ||
| Common Metric Conversions | xviii | ||
| Section I: Critical Care Intravenous Infusion Drugs-Quick Mixing Guide | 1 | ||
| Abciximab (Reopro) | 2 | ||
| Alteplase (Activase) | 2 | ||
| Aminophylline (Theophylline) 500 mg in 500 mL D5W | 2 | ||
| Amiodarone (Cordarone) | 2 | ||
| Argatroban (Acova) 250 mg in 250 mL NS | 2 | ||
| Atracurium (Tracrium) 250 mg (25 mL) in 250 mL D5W | 2 | ||
| Bivalirudin (Angiomax) 250 mg (5 mL) in 50 mL D5W | 2 | ||
| Cisatracurium (Nimbex) 250 mg in 250 mL D5W | 2 | ||
| Conivaptan (Vaprisol) | 3 | ||
| Dexmedetomidine (Precedex) 2 mg in 50 mL NS | 3 | ||
| Diltiazem (Cardizem) 125 mg in 100 mL D5W | 3 | ||
| Dobutamine (Dobutrex) 500 mg in 250 mL D5W | 3 | ||
| Dopamine (Intropin) 400 mg in 250 mL D5W | 3 | ||
| Drotrecogin Alfa (Xigris) (2 x 5 mg) 10 mg in 100 mL NS | 3 | ||
| Epinephrine (Adrenalin) 1 mg in 250 mL D5W or NS | 3 | ||
| Eptifibatide (Integrilin) 75 mg in 100-mL Vial | 3 | ||
| Esmolol (Brevibloc) 2.5 g in 250 mL D5W or NS | 4 | ||
| Fenoldopam (Corlopam) 10 mg in 250 mL D5W or NS | 4 | ||
| Haloperidol (Haldol) for Rapid Tranquilization | 4 | ||
| Heparin 25,000 Units in 500 mL D5W | 4 | ||
| Ibutilide (Corvert) 1 mg in 50 mL D5W or NS | 4 | ||
| Immune Globulin Doses | 4 | ||
| Inamrinone (Inocor) 500 mg in 100 mL NS | 4 | ||
| Infliximab (Remicade) 100 mg to 900 mg in 250 mL NS | 4 | ||
| Insulin 100 Units in 250 mL NS | 5 | ||
| Isoproterenol (Isuprel) 1 mg in 250 mL D5W | 5 | ||
| Labetalol (Trandate) 200 mg in 200 mL NS | 5 | ||
| Lepirudin (Refludan) 100 mg in 250 mL NS | 5 | ||
| Lidocaine 2 g in 500 mL D5W | 5 | ||
| Lorazepam (Ativan) 40 mg in 500 mL D5W | 5 | ||
| Magnesium Sulfate (MgSO4) | 5 | ||
| Midazolam (Versed) 125 mg in 125 mL NS | 6 | ||
| Milrinone (Primacor) 20 mg in 100 mL D5W | 6 | ||
| Nesiritide (Natrecor) 1.5 mg in 250 mL D5W | 6 | ||
| Nicardipine (Cardene) | 6 | ||
| Nitroglycerin 25 mg in 250 mL D5W | 6 | ||
| Nitroprusside (Nipride) 50 mg in 500 mL D5W | 6 | ||
| Norepinephrine (Levophed) 4 mg in 250 mL D5W or NS with Regitine 5 mg/250 mL | 6 | ||
| Octreotide (Sandostatin) 1200 mcg in 250 mL D5W or NS | 7 | ||
| Pantoprazole (Protonix) 40-80 mg in 100 mL D5W or NS | 7 | ||
| Phenylephrine (Neo-Synephrine) 10 mg in 250 mL D5W | 7 | ||
| Potassium Chloride (KCl) | 7 | ||
| Procainamide (Pronestyl) 1 g in 250 mL D5W or NS | 7 | ||
| Propofol (Diprivan) 500 mg/50 mL or 1 g/100 mL Emulsion | 7 | ||
| Reteplase (Retavase) 20-Unit Kit | 8 | ||
| Tenecteplase (TNKase) | 8 | ||
| Tirofiban (Aggrastat) 12.5 mg in 250 mL D5W or NS | 8 | ||
| Vasopressin (Pitressin Synthetic) 250 Units in 250 mL | 8 | ||
| Section II: Intravenous Infusion Drugs | 53 | ||
| Abciximab (ReoPro) | 54 | ||
| Uses | 54 | ||
| Solution Preparation | 54 | ||
| Dose | 54 | ||
| Warnings | 54 | ||
| Adverse Reactions | 54 | ||
| Incompatibility | 55 | ||
| Nursing Considerations | 55 | ||
| Alteplase (Activase) | 59 | ||
| Uses | 59 | ||
| Solution Preparation | 59 | ||
| Dose | 59 | ||
| Warnings | 59 | ||
| Adverse Reactions | 60 | ||
| Incompatibility | 60 | ||
| Compatibility | 60 | ||
| Nursing Considerations | 60 | ||
| Aminophylline (Theophylline) | 63 | ||
| Uses | 63 | ||
| Solution Preparation | 63 | ||
| Dose | 63 | ||
| Warnings | 63 | ||
| Adverse Reactions | 64 | ||
| Incompatibility | 64 | ||
| Compatibility | 64 | ||
| Nursing Considerations | 65 | ||
| Amiodarone (Cordarone) | 67 | ||
| Uses | 67 | ||
| Solution Preparation | 67 | ||
| Dose | 67 | ||
| Warnings | 68 | ||
| Adverse Reactions | 68 | ||
| Incompatibility | 69 | ||
| Compatibility | 69 | ||
| Nursing Considerations | 71 | ||
| Argatroban (Acova) | 73 | ||
| Uses | 73 | ||
| Solution Preparation | 73 | ||
| Doses | 73 | ||
| Warnings | 73 | ||
| Adverse Reactions | 74 | ||
| Incompatibilities | 74 | ||
| Nursing Considerations | 74 | ||
| Atracurium (Tracrium) | 77 | ||
| Uses | 77 | ||
| Solution Preparation | 77 | ||
| Dose | 77 | ||
| Warnings | 77 | ||
| Adverse Reactions | 77 | ||
| Incompatibility | 77 | ||
| Compatibility | 78 | ||
| Nursing Considerations | 78 | ||
| Bivalirudin (Angiomax) | 80 | ||
| Uses | 80 | ||
| Solution Preparation | 80 | ||
| Dose | 80 | ||
| Warnings | 82 | ||
| Adverse Reactions | 82 | ||
| Incompatibility (Including Y-Site) | 82 | ||
| Compatibility | 82 | ||
| Nursing Considerations | 82 | ||
| Cisatracurium (Nimbex) | 85 | ||
| Uses | 85 | ||
| Solution Preparation | 85 | ||
| Dose | 85 | ||
| Warnings | 85 | ||
| Adverse Reactions | 85 | ||
| Incompatibility | 85 | ||
| Compatibility (Via Y-Site Administration) | 86 | ||
| Nursing Considerations | 87 | ||
| Conivaptan (Vaprisol) | 89 | ||
| Uses | 89 | ||
| Solution Preparation | 89 | ||
| Dose | 89 | ||
| Warnings | 89 | ||
| Adverse Reactions | 89 | ||
| Incompatibilities | 90 | ||
| Nursing Considerations | 90 | ||
| Dexmedetomidine (Precedex) | 92 | ||
| Uses | 92 | ||
| Solution Preparation | 92 | ||
| Dose | 92 | ||
| Warnings | 92 | ||
| Adverse Reactions | 92 | ||
| Incompatibility | 93 | ||
| Compatibility | 93 | ||
| Nursing Considerations | 93 | ||
| Diltiazem (Cardizem) | 95 | ||
| Uses | 95 | ||
| Solution Preparation | 95 | ||
| Dose | 95 | ||
| Warnings | 95 | ||
| Adverse Reactions | 96 | ||
| Incompatibility | 96 | ||
| Compatibility | 96 | ||
| Nursing Considerations | 97 | ||
| Dobutamine (Dobutrex) | 99 | ||
| Uses | 99 | ||
| Solution Preparation | 99 | ||
| Dose | 99 | ||
| Warnings | 99 | ||
| Adverse Reactions | 100 | ||
| Incompatibility | 100 | ||
| Compatibility | 100 | ||
| Nursing Considerations | 101 | ||
| Dopamine (Intropin) | 107 | ||
| Uses | 107 | ||
| Solution Preparation | 107 | ||
| Dose | 107 | ||
| Warnings | 107 | ||
| Adverse Reactions | 107 | ||
| Incompatibility | 108 | ||
| Compatibility | 108 | ||
| Nursing Considerations | 109 | ||
| Drotrecogin Alfa (Xigris) | 115 | ||
| Uses | 115 | ||
| Solution Preparation | 115 | ||
| Dose | 115 | ||
| Contraindications | 115 | ||
| Warnings | 116 | ||
| Adverse Reactions | 116 | ||
| Incompatibility | 116 | ||
| Nursing Considerations | 116 | ||
| Epinephrine (Adrenalin) Injection | 123 | ||
| Uses | 123 | ||
| Solution Preparation | 123 | ||
| Dose | 123 | ||
| Warnings | 123 | ||
| Adverse Reactions | 124 | ||
| Incompatibility | 124 | ||
| Compatibility | 124 | ||
| Nursing Considerations | 124 | ||
| Eptifibatide (Integrilin) | 128 | ||
| Uses | 128 | ||
| Solution Preparation | 128 | ||
| Dose | 128 | ||
| Warnings | 128 | ||
| Adverse Reactions | 129 | ||
| Incompatibility | 129 | ||
| Compatibility | 129 | ||
| Nursing Considerations | 129 | ||
| Esmolol (Brevibloc) | 133 | ||
| Uses | 133 | ||
| Solution Preparation | 133 | ||
| Dose | 133 | ||
| Warnings | 133 | ||
| Adverse Reactions | 133 | ||
| Incompatibility | 133 | ||
| Compatibility | 134 | ||
| Nursing Considerations | 134 | ||
| Fenoldopam (Corlopam) | 136 | ||
| Uses | 136 | ||
| Solution Preparation | 136 | ||
| Dose | 136 | ||
| Warnings | 136 | ||
| Adverse Reactions | 136 | ||
| Drug Interactions | 137 | ||
| Incompatibility | 137 | ||
| Compatibility | 137 | ||
| Nursing Considerations | 137 | ||
| Haloperidol (Haldol) | 139 | ||
| Uses | 139 | ||
| Solution Preparation | 139 | ||
| Dose | 139 | ||
| Warnings | 139 | ||
| Adverse Reactions | 139 | ||
| Incompatibility | 139 | ||
| Compatibility | 140 | ||
| Nursing Considerations | 140 | ||
| Heparin | 139 | ||
| Uses | 141 | ||
| Solution Preparation | 141 | ||
| Dose | 141 | ||
| Warnings | 141 | ||
| Adverse Reactions | 142 | ||
| Incompatibility | 142 | ||
| Compatibility | 142 | ||
| Nursing Considerations | 143 | ||
| Ibutilide (Corvert) | 148 | ||
| Uses | 148 | ||
| Solution Preparation | 148 | ||
| Dose | 148 | ||
| Warnings | 148 | ||
| Adverse Reactions | 148 | ||
| Incompatibility/Interactions | 149 | ||
| Nursing Considerations | 149 | ||
| Immune Globulin Intravenous: (Carimune, Gamimune, Gammagard, Gammar-P, Gamunex, Iveegam, Octagam, Panglobulin, Polygam, Sandoglobulin,...) | 150 | ||
| Uses | 150 | ||
| Solution Preparation | 150 | ||
| Dose | 150 | ||
| Warnings | 150 | ||
| Adverse Reactions | 150 | ||
| Incompatibility | 151 | ||
| Compatibility | 151 | ||
| Nursing Considerations | 151 | ||
| Inamrinone (Inocor) | 154 | ||
| Uses | 154 | ||
| Solution Preparation | 154 | ||
| Dose | 154 | ||
| Warnings | 154 | ||
| Adverse Reactions | 155 | ||
| Incompatibility | 155 | ||
| Compatibility | 155 | ||
| Nursing Considerations | 156 | ||
| Infliximab (Remicade) | 161 | ||
| Uses | 161 | ||
| Solution Preparation | 161 | ||
| Dose | 161 | ||
| Contraindications | 161 | ||
| Warnings | 161 | ||
| Adverse Reactions | 162 | ||
| Incompatibility | 162 | ||
| Nursing Considerations | 162 | ||
| Insulin Drip | 161 | ||
| Uses | 165 | ||
| Solution Preparation | 165 | ||
| Dose | 165 | ||
| Warnings | 165 | ||
| Adverse Reactions | 165 | ||
| Incompatibility | 165 | ||
| Compatibility | 165 | ||
| Nursing Considerations | 166 | ||
| Isoproterenol (Isuprel) | 168 | ||
| Uses | 168 | ||
| Solution Preparation | 168 | ||
| Dose | 168 | ||
| Warnings | 168 | ||
| Adverse Reactions | 169 | ||
| Incompatibility | 169 | ||
| Compatibility | 169 | ||
| Nursing Considerations | 170 | ||
| Labetalol (Trandate) | 173 | ||
| Uses | 173 | ||
| Solution Preparation | 173 | ||
| Dose | 173 | ||
| Warnings | 173 | ||
| Adverse Reactions | 174 | ||
| Incompatibility | 174 | ||
| Compatibility | 174 | ||
| Nursing Considerations | 175 | ||
| Lepirudin (Refludan) | 177 | ||
| Uses | 177 | ||
| Solution Preparation | 177 | ||
| Dose | 177 | ||
| Warnings | 177 | ||
| Adverse Reactions | 177 | ||
| Incompatibility | 178 | ||
| Compatibility | 178 | ||
| Nursing Considerations | 178 | ||
| Lidocaine (Xylocaine) | 181 | ||
| Uses | 181 | ||
| Solution Preparation | 181 | ||
| Dose | 181 | ||
| Warnings | 181 | ||
| Adverse Reactions | 182 | ||
| Incompatibility | 182 | ||
| Compatibility | 182 | ||
| Nursing Considerations | 183 | ||
| Lorazepam (Ativan) | 185 | ||
| Uses | 185 | ||
| Solution Preparation | 185 | ||
| Dose | 185 | ||
| Warnings | 185 | ||
| Adverse Reactions | 185 | ||
| Incompatibility | 186 | ||
| Compatibility | 186 | ||
| Nursing Considerations | 187 | ||
| Magnesium Sulfate (MgSO4) | 189 | ||
| Use | 189 | ||
| Preparation | 189 | ||
| Dose | 189 | ||
| Warnings | 189 | ||
| Adverse Reactions (Related To Excessive Magnesium Levels) | 189 | ||
| Incompatibility | 190 | ||
| Compatibility | 190 | ||
| Nursing Considerations | 191 | ||
| Midazolam (Versed) | 193 | ||
| Uses | 193 | ||
| Solution Preparation | 193 | ||
| Dose | 193 | ||
| Warnings | 193 | ||
| Adverse Reactions | 193 | ||
| Incompatibility | 193 | ||
| Compatibility | 194 | ||
| Nursing Considerations | 194 | ||
| Milrinone (Primacor) | 196 | ||
| Uses | 196 | ||
| Solution Preparation | 196 | ||
| Dose | 196 | ||
| Warnings | 196 | ||
| Adverse Reactions | 197 | ||
| Incompatibility | 197 | ||
| Compatibility | 197 | ||
| Nursing Considerations | 198 | ||
| Nesiritide (Natrecor) | 201 | ||
| Uses | 201 | ||
| Solution Preparation | 201 | ||
| Dose | 201 | ||
| Warnings | 201 | ||
| Adverse Reactions | 202 | ||
| Incompatibility | 202 | ||
| Compatible Solutions | 202 | ||
| Nursing Considerations | 202 | ||
| Nicardipine (Cardene) | 204 | ||
| Uses | 204 | ||
| Solution Preparation | 204 | ||
| Dose | 204 | ||
| Warnings | 204 | ||
| Adverse Reactions | 205 | ||
| Compatible Solutions | 205 | ||
| Compatibility | 205 | ||
| Incompatibility | 206 | ||
| Nursing Considerations | 206 | ||
| Nitroglycerin | 208 | ||
| Uses | 208 | ||
| Solution Preparation | 208 | ||
| Dose | 208 | ||
| Warnings | 208 | ||
| Adverse Reactions | 209 | ||
| Incompatibility | 209 | ||
| Compatibility (Via Y Site) | 209 | ||
| Nursing Considerations | 209 | ||
| Nitroprusside (Nipride) | 212 | ||
| Uses | 212 | ||
| Solution Preparation | 212 | ||
| Dose | 212 | ||
| Warnings | 212 | ||
| Adverse Reactions | 213 | ||
| Incompatibility | 213 | ||
| Compatibility | 213 | ||
| Nursing Considerations | 213 | ||
| Norepinephrine (Levophed) | 224 | ||
| Uses | 224 | ||
| Solution Preparation | 224 | ||
| Dose | 224 | ||
| Warnings | 224 | ||
| Adverse Reactions | 225 | ||
| Incompatibility | 225 | ||
| Compatibility | 226 | ||
| Nursing Considerations | 226 | ||
| Octreotide (Sandostatin) | 232 | ||
| Uses | 232 | ||
| Solution Preparation | 232 | ||
| Dose | 232 | ||
| Warnings | 232 | ||
| Adverse Reactions | 232 | ||
| Incompatibility | 232 | ||
| Compatibility | 232 | ||
| Nursing Considerations | 232 | ||
| Pantoprazole (Protonix) | 234 | ||
| Uses | 234 | ||
| Solution Preparation | 234 | ||
| Dose | 234 | ||
| Warnings | 234 | ||
| Adverse Reactions | 235 | ||
| Incompatibility | 235 | ||
| Compatibility | 235 | ||
| Nursing Considerations | 235 | ||
| Phenylephrine (Neo-Synephrine) | 237 | ||
| Uses | 237 | ||
| Solution Preparation | 237 | ||
| Dose | 237 | ||
| Warnings | 237 | ||
| Adverse Reactions | 237 | ||
| Incompatibility | 238 | ||
| Compatibility | 238 | ||
| Nursing Considerations | 238 | ||
| Potassium Chloride (KCl) | 240 | ||
| Use | 240 | ||
| Preparation | 240 | ||
| Dose | 240 | ||
| Warnings | 240 | ||
| Adverse Reactions | 241 | ||
| Incompatibility | 241 | ||
| Compatibility | 241 | ||
| Nursing Considerations | 244 | ||
| Procainamide (Pronestyl) | 245 | ||
| Uses | 245 | ||
| Solution Preparation | 245 | ||
| Dose | 245 | ||
| Warnings | 245 | ||
| Adverse Reactions | 246 | ||
| Incompatibility | 246 | ||
| Compatibility | 246 | ||
| Nursing Considerations | 246 | ||
| Propofol (Diprivan) | 249 | ||
| Uses | 249 | ||
| Solution Preparation | 249 | ||
| Dose | 249 | ||
| Warnings | 249 | ||
| Adverse Reactions | 249 | ||
| Incompatibility | 249 | ||
| Compatibility | 250 | ||
| Nursing Considerations | 251 | ||
| Reteplase (Retavase) | 253 | ||
| Uses | 253 | ||
| Solution Preparation | 253 | ||
| Dose | 253 | ||
| Warnings | 253 | ||
| Adverse Reactions | 253 | ||
| Incompatibility | 254 | ||
| Compatibility | 254 | ||
| Nursing Considerations | 254 | ||
| Tenecteplase (TNKase) | 255 | ||
| Uses | 255 | ||
| Solution Preparation | 255 | ||
| Dose | 255 | ||
| Warnings | 255 | ||
| Adverse Reactions | 255 | ||
| Incompatibility | 256 | ||
| Compatibility | 256 | ||
| Nursing Considerations | 256 | ||
| Tirofiban HCl (Aggrastat) | 258 | ||
| Uses | 258 | ||
| Solution Preparation | 258 | ||
| Dose | 258 | ||
| Warnings | 258 | ||
| Adverse Reactions | 259 | ||
| Incompatibility | 259 | ||
| Compatibility | 259 | ||
| Nursing Considerations | 259 | ||
| Vasopressin (Pitressin) | 262 | ||
| Uses | 262 | ||
| Solution Preparation | 262 | ||
| Dose | 262 | ||
| Warnings | 262 | ||
| Adverse Reactions | 263 | ||
| Incompatibility | 263 | ||
| Nursing Considerations | 263 | ||
| Section III: ACLS Guidelines for Adult Emergency Cardiac Care Algorithms | 267 | ||
| Pulseless Ventricular Tachycardia (VT)/Ventricular Fibrillation (VF) | 268 | ||
| Asystole | 271 | ||
| Pulseless Electrical Activity (PEA) | 274 | ||
| Pulseless Electrical Activity (PEA): Clinical Signs and Treatment | 277 | ||
| Symptomatic Bradycardia | 283 | ||
| Narrow QRS Tachycardia | 286 | ||
| Atrial Fibrillation/Atrial Flutter Algorithm | 291 | ||
| Wolff-Parkinson-White (WPW) Syndrome Algorithm | 296 | ||
| Sustained Monomorphic Ventricular Tachycardia | 300 | ||
| Polymorphic Ventricular Tachycardia | 304 | ||
| Wide QRS Tachycardia of Unknown Origin | 309 | ||
| Initial Assessment and General Treatment of the Patient with anAcute Coronary Syndrome (ACS) | 313 | ||
| Management of ST-Segment Elevation Myocardial Infarction (MI) | 316 | ||
| Management of Unstable Angina/Non–ST-Segment Elevation MyocardialInfarction (MI) | 319 | ||
| Management of Patient with a Suspected Acute Coronary Syndrome andNondiagnostic or Normal ECG | 321 | ||
| Management of Acute Pulmonary Edema | 322 | ||
| Management of Hypotension/Shock: Suspected Pump Problem | 326 | ||
| Management of Hypotension/Shock: Suspected Volume Problem | 330 | ||
| Management of Hypotension/Shock: Suspected Rate Problem | 332 | ||
| Index | 334 |